Continue reading Stack3d

Check out Stack3d's most popular stories before you go

Ghost is getting back into ready-to-drink protein with an authentic Yoo-hoo chocolate flavorGhost is getting back into ready-to-drink protein with an authentic Yoo-hoo chocolate flavorArnold Expo is going to be a four-day show next year after its hugely successful 2026 eventArnold Expo is going to be a four-day show next year after its hugely successful 2026 eventPrime becomes the hydration sponsor of the legendary Diamond Gym and makes a special edition drinkPrime becomes the hydration sponsor of the legendary Diamond Gym and makes a special edition drinkDavid shares the first look at its ice cream with 30g of protein and only 260 caloriesDavid shares the first look at its ice cream with 30g of protein and only 260 caloriesDoritos Protein Chips use milk protein to build up to 10g of protein per servingDoritos Protein Chips use milk protein to build up to 10g of protein per servingBarebells expands its Gooey Protein Bar with a rich and smooth Pistachio Spread flavorBarebells expands its Gooey Protein Bar with a rich and smooth Pistachio Spread flavor

Flexatril getting smaller tablets for easier swallowing

flexatril

There are very few times where we get proof that a brand has listened to its fans and taken action. This is one of those times, as today Scivation has announced that it’s made a small but noticeable change to its joint support supplement Flexatril. If you haven’t tried the product before it won’t really matter to you, however if you’re a loyal user then you are going to want to hear this.

Basically the brand has decided to make Flexatril’s tablets a little smaller, to make it easier to take the supplement. This has of course resulted in Scivation needing to increase the amount of tablets you take, so very soon you will be seeing a 120 count Flexatril featuring a four tablet serving instead of three. Every ingredient and dose is said to be exactly the same, with the tablet size being the only difference.

In this post:
COMMENTS